Workflow
Salarius Pharmaceuticals(SLRX)
icon
Search documents
Salarius Pharmaceuticals (SLRX) Investor Presentation - Slideshow
2020-09-02 23:00
Company Overview 3Q 2020 © 2020 Salarius Pharmaceuticals, Inc. Non Confidential Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement in this presentation that is not a historical fact is a forward-looking statement. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication o ...
Salarius Pharmaceuticals(SLRX) - 2020 Q2 - Earnings Call Transcript
2020-08-13 02:49
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Q2 2020 Earnings Conference Call August 12, 2020 4:30 PM ET Company Participants David Arthur - CEO, President & Director Mark Rosenblum - EVP, Finance & CFO Nadeem Mirza - SVP, Clinical Development Daniela Santiesteban - Director, Research and Business Development Conference Call Participants Aydin Huseynov - The Benchmark Company Wangzhi Li - Ladenburg Thalmann & Co. Hunter Diamond - Diamond Equity Research Patrick Doolan - Old Peak Road Operator Ladies and gen ...
Salarius Pharmaceuticals(SLRX) - 2020 Q1 - Earnings Call Transcript
2020-05-15 00:19
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Jason Rando - EVP & COO, Tiberend Strategic Advisors, Inc., IR David Arthur - President and CEO Mark Rosenblum - CFO Daniela Santiesteban - Director of Business Development and Research Conference Call Participants Hunter Diamond - Diamond Equity Research LLC Wangzhi Li - Ladenburg Thalmann & Co. Inc Operator Ladies and gentlemen, thank you for standing by, and welcome to the Q1, 2020 S ...
Salarius Pharmaceuticals (SLRX) Investor Presentation - Slideshow
2020-02-21 19:19
Company Overview 1Q 2020 © 2020 Salarius Pharmaceuticals, Inc. Safe Harbor Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement in this presentation that is not a historical fact is a forward-looking statement. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performa ...